Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2000-5-4
pubmed:abstractText
The catalytic antibody 4B2, which was generated against a substituted amidine 1, catalyses the allylic isomerization of beta, gamma-unsaturated ketones with an acceleration factor (k(cat)/k(uncat)) of 1.5x10(3). On the basis of the 'bait and switch' strategy, it was reasoned that the positively charged hapten could elicit, by charge complementarity, an acidic residue (Asp or Glu) in the antibody-binding site in the right position to catalyse this proton transfer reaction. The pH dependence curve of k(cat)/K(m) shows a bell-shaped feature with an optimum at approx. pH 4.5. By cloning and sequencing the light and heavy chains of the 4B2 antibody, we confirmed the presence of several Asp and Glu residues in the complementarity-determining region loops. The antibody catalyses the alpha-proton exchange on the same substrates, demonstrating the involvement of a dienol intermediate in the reaction mechanism. Kinetic studies with (2)H-NMR provide evidence that alpha-proton abstraction is stereospecific. Whether the process involves one or two acid/base residues in this simple proton transfer or whether it is a concerted mechanism is discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-1172191, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-13140346, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-2271654, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-2531466, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-3681981, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-3683403, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-3981007, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-7809611, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-7816136, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-7993901, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-7994617, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-8292607, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-9103200, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-9342312, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-9399859, http://linkedlifedata.com/resource/pubmed/commentcorrection/10698695-9622484
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
346 Pt 3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
691-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Mechanism of an antibody-catalysed allylic isomerization.
pubmed:affiliation
UPRES no. 2161 'Biocatalyse', Faculté des Sciences et des Techniques, 2 rue de la Houssinière, BP 92208, 44322 Nantes Cedex 03, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't